Cargando...
Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C
The recent introduction of direct-acting antiviral drugs (DAAs) for treatment of the hepatitis C virus (HCV) has greatly improved the management of HCV for infected patients. These viral protein inhibitors act rapidly, allowing HCV clearance and increasing the sustained virological response rates. H...
Guardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5487495/ https://ncbi.nlm.nih.gov/pubmed/28706414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i24.4317 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|